EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

Trial Profile

EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

Completed
Phase of Trial: Phase III

Latest Information Update: 24 May 2017

At a glance

  • Drugs Loxapine (Primary) ; Aripiprazole
  • Indications Bipolar I disorders; Schizophrenia
  • Focus Registrational; Therapeutic Use
  • Acronyms PLACID
  • Sponsors Ferrer
  • Most Recent Events

    • 03 Feb 2017 Status changed from recruiting to completed.
    • 25 Jan 2017 This trial was completed in Czech Republic (end date: 2016-10-31), according to European Clinical Trials Database.
    • 11 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top